Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-cell depleted PBSCT with delayed T-cell add-back for hematological malignancies
NCT00378534Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 2006
- Primary completion
- Apr 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34-selected peripheral blood stem cells in chronic myelogenous leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), sponsored by National Heart, Lung, and Blood Institute. Started Sep 2006; status: completed.
02
Drugs
CD34-selected peripheral blood stem cells
03
Conditions
chronic myelogenous leukemia (CML)acute myeloid leukemia (AML)chronic lymphocytic leukemia (CLL)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00378534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378534.